Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
First in humans studies of the pharmacology of boldine
Gurvich, V. J. (PI), Wong, H. L. (CoI), Gallardo-Macias, R. (Other Role), Goode, A. J. (Other Role) & John, K. E. (Other Role)
THE BRONX VETERANS MEDICAL RESEARCH FDN, STATE OF NEW YORK
7/1/25 → 6/30/26
Project: Research project
-
Triptonide Prodrugs
Georg, G. (PI), Wong, H. L. (CoI), Jakkaraj, S. R. (Other Role), John, K. E. (Other Role) & Vantaddu, N. R. (Other Role)
12/15/24 → 8/31/25
Project: Research project
Research output
- 12 Article
-
Development of a Second-Generation RARα Selective Antagonist as an Orally Bioavailable, Effective, Safe, and Reversible Male Contraceptive
Shi, R., John, K., Qin, X., Haque, E., Liang, T., Cheryala, N., Li, F., Wong, H. L. & Georg, G. I., May 28 2026, In: Journal of medicinal chemistry. 69, 10, p. 12144-12170 27 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)]
Ericson, M. D., Freeman, K. T., Larson, C. M., Bouchard, J. L., John, K., Lunzer, M. M., Koerperich, Z. M. & Haskell-Luevano, C., Apr 12 2024, In: ACS Pharmacology and Translational Science. 7, 4, p. 1114-1125 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding
Faber, E. B., Sun, L., Tang, J., Roberts, E., Ganeshkumar, S., Wang, N., Rasmussen, D., Majumdar, A., Hirsch, L. E., John, K., Yang, A., Khalid, H., Hawkinson, J. E., Levinson, N. M., Chennathukuzhi, V., Harki, D. A., Schönbrunn, E. & Georg, G. I., Dec 2023, In: Nature communications. 14, 1, 3213.Research output: Contribution to journal › Article › peer-review
Open Access40 Link opens in a new tab Scopus citations -
Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2′)-Orn-NH2] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2′)-Arg-NH2]
Ericson, M. D., Tran, L. T., Mathre, S. S., Freeman, K. T., Holdaway, K., John, K., Lunzer, M. M., Bouchard, J. L. & Haskell-Luevano, C., Jun 22 2023, In: Journal of medicinal chemistry. 66, 12, p. 8103-8117 15 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice
Faber, E. B., Wang, N., John, K., Sun, L., Wong, H. L., Burban, D., Francis, R., Tian, D., Hong, K. H., Yang, A., Wang, L., Elsaid, M., Khalid, H., Levinson, N. M., Schönbrunn, E., Hawkinson, J. E. & Georg, G. I., Feb 9 2023, In: Journal of medicinal chemistry. 66, 3, p. 1928-1940 13 p.Research output: Contribution to journal › Article › peer-review
Open Access28 Link opens in a new tab Scopus citations